Amelia Tienghi, MD | Authors

Doxorubicin and Paclitaxel (Sequential Combination) in the Treatment

April 01, 1997

Based on preclinical data, we designed a phase I/II clinical trial to determine the efficacy and toxicity of doxorubicin followed by paclitaxel in the treatment of advanced breast cancer (either untreated or relapsed after